[Recalled] One Step P in vitro diagnostic test REF: 8194 — The devices were distributed without required FDA premarket clearance or approv… | FDA 2026-04-02
This is an official product-safety recall record. Below are the verified details from the issuing authority, in plain language.
Recall details
| Product | One Step P in vitro diagnostic test REF: 8194 |
|---|---|
| Brand / manufacturer | DFI Co., Ltd. |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-2088-2026 |
| Country of notice | Korea (the Republic of) |
| Risk level | Class II |
| Hazard type | recall |
| Notice date | 02 April 2026 |
| EAN / barcode | 08806141302025 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: The devices were distributed without required FDA premarket clearance or approval.
This Class II recall concerns device products distributed in Korea (the Republic of) and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Check whether your unit is affected and follow the authority's guidance before further use.
Read the full official notice →
Related recalls from DFI Co., Ltd.
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.
- Fiction, Science Fiction, and Allergy-Free Reading: A Guide for Sensitive Readers
- Healthiest Toppings & Ingredients Options for a Nutritious Diet
- Qu'est-ce que 2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethanol (CAS 2315-67-5) ? Sécurité, réglementation & perspective UE/États-Unis/Canada | ProductGuru
- Top Organic Books and Stationery Brands for a Greener Creative Life
- Best Printer Ink and Toner 2026: A Comprehensive Guide for 2026
- How to Start Investing With $1,000